These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36380508)

  • 1. Risk factors and prediction nomogram model for 1-year readmission for major adverse cardiovascular events in patients with STEMI after PCI.
    Yao W; Li J
    Clin Appl Thromb Hemost; 2022; 28():10760296221137847. PubMed ID: 36380508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Fang C; Chen Z; Zhang J; Jin X; Yang M
    Front Cardiovasc Med; 2022; 9():1050785. PubMed ID: 36620648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.
    Qiu H; Zhu Y; Shen G; Wang Z; Li W
    Clin Interv Aging; 2023; 18():453-465. PubMed ID: 36987461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the Risk of Unplanned Readmission at 30 Days After PCI: Development and Validation of a New Predictive Nomogram.
    Xu W; Tu H; Xiong X; Peng Y; Cheng T
    Clin Interv Aging; 2022; 17():1013-1023. PubMed ID: 35818480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI.
    Gao N; Qi X; Dang Y; Li Y; Wang G; Liu X; Zhu N; Fu J
    BMC Cardiovasc Disord; 2020 Dec; 20(1):513. PubMed ID: 33297955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model.
    Ye Z; Xu Y; Tang L; Wu M; Wu B; Zhu T; Wang J
    Cardiovasc Diabetol; 2023 Apr; 22(1):87. PubMed ID: 37055777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a nomogram for the prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: a multicentre, retrospective, observational study in Hebei province, China.
    Wang Y; Wang W; Jia S; Gao M; Zheng S; Wang J; Dang Y; Li Y; Qi X
    BMJ Open; 2022 Feb; 12(2):e056101. PubMed ID: 35110324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a nomogram model for predicting in-hospital mortality risk in patients with acute ST-elevation myocardial infarction and acute heart failure post-PCI.
    Yu F; Xu Y; Peng J
    Scand Cardiovasc J; 2024 Dec; 58(1):2387001. PubMed ID: 39092557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction.
    Zhao E; Xie H; Zhang Y
    Cardiovasc Ther; 2020; 2020():9416803. PubMed ID: 32099583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radiomic nomogram for prediction of major adverse cardiac events in ST-segment elevation myocardial infarction.
    Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
    Eur Radiol; 2021 Feb; 31(2):1140-1150. PubMed ID: 32856164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of the nomogram model of clinical risk factors for ischemia-reperfusion injury after primary percutaneous coronary intervention.
    Wang Z; Peng J
    Sci Rep; 2023 Mar; 13(1):5084. PubMed ID: 36977721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study.
    Zhang KP; Guo QC; Mu N; Liu CH
    Medicine (Baltimore); 2024 Jun; 103(24):e38563. PubMed ID: 38875361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and validation of a predictive model for major adverse cardiovascular events in the long term after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Yang Y; Yin X; Zhang Y; Ren L
    Coron Artery Dis; 2024 Sep; 35(6):471-480. PubMed ID: 38656258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of Nomogram for the Prediction of Malignant Ventricular Arrhythmia Including Circulating Inflammatory Cells in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Wang L; Yang L; Li T; Geng S
    J Inflamm Res; 2023; 16():3185-3196. PubMed ID: 37529768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a predictive model for adverse left ventricular remodeling in NSTEMI patients after primary percutaneous coronary intervention.
    Wang L; Liu T; Wang C; Xuan H; Xu X; Yin J; Li X; Chen J; Li D; Xu T
    BMC Cardiovasc Disord; 2022 Aug; 22(1):386. PubMed ID: 36030211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram for Predicting In-Hospital Mortality in Patients with Acute ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock after Primary Percutaneous Coronary Intervention.
    Wang Y; Liu L; Li X; Dang Y; Li Y; Wang J; Qi X
    J Interv Cardiol; 2022; 2022():8994106. PubMed ID: 35356419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.
    Liu Y; Ye T; Chen K; Wu G; Xia Y; Wang X; Zong G
    Front Cardiovasc Med; 2022; 9():966299. PubMed ID: 36003914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal data-driven prognostic model for predicting new-onset ST-elevation myocardial infarction following emergency percutaneous coronary intervention.
    Tang L; Wu M; Xu Y; Zhu T; Fang C; Ma K; Wang J
    Inflamm Res; 2023 Sep; 72(9):1799-1809. PubMed ID: 37644338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and validation of a nomogram model containing a triglyceride-glucose index and neutrophil-to-high-density lipoprotein ratio for predicting major adverse cardiac events in patients with ST-segment elevation myocardial infarction.
    Xu ZC; Pang LM; Chen M; Hu GQ
    J Int Med Res; 2024 Sep; 52(9):3000605241258181. PubMed ID: 39291425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Predictive Model for Chronic Kidney Disease After Percutaneous Coronary Intervention in Chinese.
    Zhang Y; Wang J; Zhai G; Zhou Y
    Clin Appl Thromb Hemost; 2022; 28():10760296211069998. PubMed ID: 35073208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.